Search

Author/Creator Azad, Arun

2. TheraP: a randomized phase 2 trial of 177Lu‐PSMA‐617 theranostic treatment vs cabazitaxel in progressive metastatic castration‐resistant prostate cancer (Clinical Trial Protocol ANZUP 1603). (22nd October 2019)

Authors:
Hofman, Michael S.; Emmett, Louise; Violet, John; Y. Zhang, Alison; Lawrence, Nicola J.; Stockler, Martin; Francis, Roslyn J.; Iravani, Amir; Williams, Scott; Azad, Arun; Martin, Andrew; McJannett, Margaret; Davis, Ian D.
Journal:
BJU international
Issue:
Volume 124(2019)Supplement 1
Page Start:
5
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Real‐world use of first‐generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration‐resistant prostate cancer. Issue Volume 128:Issue Supplement 1(2021) (7th October 2021)

Authors:
Kelly, Richard; Anton, Angelyn; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew; Azad, Arun; Kwan, Edmond Michael; Spain, Lavinia; Muthusamy, Arun; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Joshua, Anthony; Pook, David; Baenziger, Olivia; Gibbs, Peter; Tran, Ben
Journal:
BJU international
Issue:
Volume 128:Issue Supplement 1(2021)
Page Start:
18
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer. Issue 10 (18th August 2021)

Authors:
Martens‐Uzunova, Elena S.; Kusuma, Gina D.; Crucitta, Stefania; Lim, Hong Kiat; Cooper, Crystal; Riches, James E.; Azad, Arun; Ochiya, Takahiro; Boyle, Glen M.; Southey, Melissa C.; Del Re, Marzia; Lim, Rebecca; Ramm, Grant A.; Jenster, Guido W.; Soekmadji, Carolina
Journal:
Journal of extracellular vesicles
Issue:
Volume 10:Issue 10(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Real-world incidence of symptomatic skeletal events and bone-modifying agent use in castration-resistant prostate cancer – an Australian multi-centre observational study. (November 2021)

Authors:
Anton, Angelyn; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew; Azad, Arun; Kwan, Edmond M.; Spain, Lavinia; Gunjur, Ashray; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Semira, Marie C.; Gibbs, Peter; Tran, Ben; Pezaro, Carmel
Journal:
European journal of cancer
Issue:
Volume 157(2021)
Page Start:
485
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. ENZA‐p trial protocol: a randomized phase II trial using prostate‐specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration‐resistant prostate cancer treated with enzalutamide (ANZUP 1901). (6th July 2021)

Authors:
Emmett, Louise; Subramaniam, Shalini; Joshua, Anthony M.; Crumbaker, Megan; Martin, Andrew; Zhang, Alison Y.; Rana, Nisha; Langford, Ailsa; Mitchell, Jenna; Yip, Sonia; Francis, Roslyn; Hofman, Michael S.; Sandhu, Shahneen; Azad, Arun; Gedye, Craig; McJannett, Margaret; Stockler, Martin R.; Davis...
Journal:
BJU international
Issue:
Volume 128:Number 5(2021)
Page Start:
642
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗